Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2003
07/17/2003CA2471754A1 Androgen receptor antagonist
07/17/2003CA2471750A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis
07/17/2003CA2471572A1 Taxane based compositions and methods of use
07/17/2003CA2471509A1 Combinations comprising epothilones and anti-metabolites
07/17/2003CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
07/17/2003CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/17/2003CA2470411A1 System for monitoring bacterial tumor treatment
07/17/2003CA2470012A1 Novel proteins and nucleic acids encoding same
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
07/17/2003CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends
07/16/2003EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme
07/16/2003EP1327448A1 Homeostasis-maintaining agents
07/16/2003EP1327149A2 Methods of high-throughput screening for internalizing antibodies
07/16/2003EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
07/16/2003EP1326990A2 Packaging of positive-strand rna virus replicon particles
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326986A2 Regulation of human sphingosine kinase-like protein
07/16/2003EP1326981A2 Pharmaceutical preparations and methods for inhibiting tumors
07/16/2003EP1326978A2 Hematopoietin receptors hpr1 and hpr2
07/16/2003EP1326972A2 Transporters and ion channels
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses
07/16/2003EP1326897A2 Humanized anti-lt-beta-r antibodies
07/16/2003EP1326896A2 Human anti-cd40 antibodies
07/16/2003EP1326894A2 Novel tumor-associated marker
07/16/2003EP1326892A2 Compositions that inhibit proliferation of cancer cells
07/16/2003EP1326876A2 Anhydro sugar derivatives of indolocarbazoles
07/16/2003EP1326875A2 Tumor proliferation inhibitors
07/16/2003EP1326874A2 Topoisomerase inhibitors
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326860A1 Quinazoline derivatives
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326638A2 Vaccines
07/16/2003EP1326633A1 Composition comprising immunogenic microparticles
07/16/2003EP1326632A2 Agents for the treatment of viral infections
07/16/2003EP1326630A2 Use of glp-1 and glp-2 peptides
07/16/2003EP1326629A2 Methods and compositions for promoting the maturation of monocytes
07/16/2003EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326618A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
07/16/2003EP1326617A1 Use of antiprogestins for the induction of apoptosis in a cell
07/16/2003EP1326615A1 Phosphoric acid salt of an integrin receptor antagonist
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326605A1 Methods for inhibiting proliferation and inducing apoptosis in cancer cells
07/16/2003EP1326600A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
07/16/2003EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS
07/16/2003EP1326589A2 Nanoparticles
07/16/2003EP1326531A2 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
07/16/2003EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1112066B1 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0975354A4 Ligand/lytic peptide compositions and methods of use
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003EP0830137B1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
07/16/2003EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring
07/16/2003CN1430675A Use of baculovirus vectors in gene therapy
07/16/2003CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof
07/16/2003CN1430599A Phenylglycine derivatives
07/16/2003CN1430597A Novel MMP-2/MMP-9 inhibitors
07/16/2003CN1430596A New gamma selective retinoids
07/16/2003CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof
07/16/2003CN1430515A Divided dose therapies with vascular damaging activity
07/16/2003CN1430512A Modulation of bone formation
07/16/2003CN1430505A Microspheres for active embolization
07/16/2003CN1429840A New human protein having cancer cell growth in hibiting function and its code sequence
07/16/2003CN1429839A New human protein having cancer inhibiting function and its code sequence
07/16/2003CN1429815A Compound N-total trans dimension methanamide derivative and its preparation method and application
07/16/2003CN1429807A Synthesis of antitumour medicine bexarotene
07/16/2003CN1429624A Lung cancer transgene vaccine and its preparation method
07/16/2003CN1429611A Greater celandine extract and its preparation method and application
07/16/2003CN1429601A Heat-Clearing away heat and toxic material and subsidence of swelling powder
07/16/2003CN1429598A Medicine of auxiliary treating after radiotherapy and chemotherapy of cancer patient
07/16/2003CN1429573A Capsule for controlling development of liver cancer
07/16/2003CN1429558A Mannosan peptide injection and its preparation and use method
07/16/2003CN1429552A Medical use of 11,11'-dideoxy wotixilin
07/16/2003CN1429544A Natural carotene soft capsule and its production method
07/16/2003CN1114690C Papilloma pseudovirus and process for preparing same
07/16/2003CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same
07/16/2003CN1114605C Novel camptothecine derivatives
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114443C Medicine for induction-differential therapy and its application
07/16/2003CN1114423C External used liquid for treating tumour, hyperplastic surgical disease
07/16/2003CN1114422C Anti-cancer Chinese-medicinal pill
07/16/2003CN1114416C Application of arsenious acid in preparing medicine for treating gynecologic tumor and lymphomatosis
1 ... 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 ... 2211